Private company

Xiamen Innovax Biotech

Chinese pharmaceutical company

Xiamen Innovax Biotech CO., LTD. (Innovax) is a Chinese company that manufactures, markets, and develops vaccines. It is headquartered in Xiamen, Fujian, China.2 Wikipedia text CC BY-SA 4.0

Last updated Oct 21, 2026.

Overview

Xiamen Innovax Biotech CO., LTD. (Innovax) is a Chinese company that manufactures, markets, and develops vaccines. It is headquartered in Xiamen, Fujian, China.2

Calendar

Drug trials and FDA: coming up

  1. Feb 28, 2027Phase 4 trial readout expected Phase 4 trial of 9-valent HPV vaccine (Cecolin 9) in Infection by Human Papilloma Virus: primary completion expected Feb 28, 2027 (ClinicalTrials.gov NCT07668271).3

Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). Trials from ClinicalTrials.gov, as the sponsor registered them (expected dates are the sponsor's own and often move); approvals and advisory committee meetings from the FDA. The FDA does not publish its decision (PDUFA) dates. The full markets calendar